Plain-English translation of NCT04679740 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study is tracking patients who receive resorbable magnesium scaffolds (RMS)—special stents designed to open blocked heart arteries and then safely dissolve over time. Researchers want to understand how well these stents work and how safe they are when used in real hospitals and clinics with patients like you who have coronary artery disease.
Traditional heart stents are permanent, but this treatment is designed to dissolve after your artery has healed, potentially reducing long-term complications. This registry collects real-world safety and performance data to better understand how this newer approach benefits patients.
You likely qualify if…
You likely don't qualify if…
You will receive a resorbable magnesium stent during a standard heart procedure. After that, you'll be enrolled in a registry where your health information and outcomes are tracked over time to monitor how well the stent works and its safety profile. Your doctor will follow standard guidelines for your care and monitoring.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Australia
Germany